EUVIMEDEUVIMED entdecken
Crossref

Activatable Enzymatic Nanoplatform Incorporated into Microneedle Patch for Relieving Tumor Hypoxia Augmented Photodynamic Therapy

Yashi Li, Youyan Li, Gang He, Xingxing Li, Rui Ding, Ruhan Yan, Jing Lin, Peng Huang iD

Advanced Materials · 2025-10 · 37 (39)

DOI: 10.1002/adma.202504258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 04.07.2025. Verfasst von Yashi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engin…. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Tumor Hypoxia, Catalase. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Shenzhen Medical Research Fund, National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical advancement of photodynamic therapy (PDT) faces entrenched impediments, particularly the suboptimal solubility of hydrophobic photosensitizers (PSs) and tumor‐associated hypoxia. Herein, a universally applicable, carrier‐free nanotherapeutic platform is devised in which catalase (CAT) functions dually as a biocatalytic oxygenator and a biocompatible scaffold for PSs encapsulation. Through self‐assembly with diverse hydrophobic PSs—including 2‐(1‐hexyloxyethyl)‐2‐divinyl‐pyropheophorbide‐a (HPPH), chlorin e6 (Ce6), and zinc (II)‐phthalocyanine (ZnPc)—CAT forms uniform and stable PS@CAT nanoparticles (NPs), obviating the necessity for supplementary nanocarriers. These nanostructures are embedded within microneedle (MN) patches, facilitating minimally invasive, spatially targeted transdermal administration. The PSs bind to the hydrophobic pocket of CAT within NPs, temporarily suppressing its bioactivity, which is restored upon NPs disassembly in the acidic tumor microenvironment (TME). This pH‐responsive “OFF‐to‐ON” mechanism orchestrates the synchronized release of PSs and reactivation of CAT, which catalyzes endogenous hydrogen peroxide (H₂O₂) to generate oxygen (O 2 ), alleviating hypoxia and augmenting O 2 availability for PDT. In vivo validation in a 4T1 murine mammary carcinoma model corroborated this approach's therapeutic superiority and biocompatibility. Collectively, the findings delineate a minimalist, multifunctional strategy to simultaneously enhance the bioavailability of PSs and overcome hypoxia in PDT for more efficacious oncologic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPhotosensitizing AgentsTumor HypoxiaCatalaseNanoparticlesAnimalsMiceChlorophyllidesCell Line, TumorPorphyrinsNeedlesFemaleIsoindolesIndolesHumansOrganometallic CompoundsHydrogen PeroxideTumor MicroenvironmentChlorophyllZinc Compounds

Stichwörter der Autor:innen

activatable enzymatic activitycancer treatmentmicroneedle patchtraceable photodynamic therapytumor microenvironment

Substanzen

Photosensitizing AgentsCatalaseChlorophyllidesphytochlorinPorphyrinsIsoindolesIndolesOrganometallic CompoundsZn(II)-phthalocyanineHydrogen Peroxide

Autor:innen und Institutionen

  • Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenz…
  • Department of Plastic and Hand Surgery, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, 81675, Munich, Germany.

ORCID-Profile: Peng Huang

Förderung

  • Shenzhen Medical Research Fund
  • National Natural Science Foundation of China
  • Shenzhen Science and Technology Innovation Program
  • China National Postdoctoral Program for Innovative Talents
  • China Postdoctoral Science Foundation
  • Research Team Cultivation Program of Shenzhen University

Zitieren

APA

Li, Y., Li, Y., He, G., Li, X., Ding, R., Yan, R., Lin, J., & Huang, P. (2025). Activatable Enzymatic Nanoplatform Incorporated into Microneedle Patch for Relieving Tumor Hypoxia Augmented Photodynamic Therapy. Advanced Materials, 37(39). https://doi.org/10.1002/adma.202504258

Vancouver

Li Y, Li Y, He G, Li X, Ding R, Yan R, et al. Activatable Enzymatic Nanoplatform Incorporated into Microneedle Patch for Relieving Tumor Hypoxia Augmented Photodynamic Therapy. Advanced Materials. 2025;37(39). doi:10.1002/adma.202504258

BibTeX
@article{Li2025,
  author = {Li, Yashi and Li, Youyan and He, Gang and Li, Xingxing and Ding, Rui and Yan, Ruhan and Lin, Jing and Huang, Peng},
  title = {Activatable Enzymatic Nanoplatform Incorporated into Microneedle Patch for Relieving Tumor Hypoxia Augmented Photodynamic Therapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {39},
  doi = {10.1002/adma.202504258}
}
Kostenlos starten →